PG
43
2
VMC
59
2
MO
57
4
DTE
42
4
IBM
67
2
STI
15
-6
GWW
65
3
O
35
4
HSY
50
5
ROK
47
-3
KMB
33
2
MDLZ
28
4
SWKS
56
8
DRI
64
4
ES
50
3
PHM
43
2
AZO
46
-2
LNC
70
-2
JNJ
54
3
XRAY
28
3
PG
43
2
VMC
59
2
MO
57
4
DTE
42
4
IBM
67
2
STI
15
-6
GWW
65
3
O
35
4
HSY
50
5
ROK
47
-3
KMB
33
2
MDLZ
28
4
SWKS
56
8
DRI
64
4
ES
50
3
PHM
43
2
AZO
46
-2
LNC
70
-2
JNJ
54
3
XRAY
28
3
Financhill
Back

Milestone Pharmaceuticals, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
44

MIST
Milestone Pharmaceuticals, Inc.

Last Price:
$2.08
Seasonality Move:
-24.48%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
44
Milestone Pharmaceuticals, Inc. (MIST) is a Sell

Is Milestone Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Milestone Pharmaceuticals, Inc. [MIST] share price is $2.07. The Score for MIST is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • MIST is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MIST Stock Price Chart

What is Milestone Pharmaceuticals, Inc.'s stock price today?

  • The Milestone Pharmaceuticals, Inc. share price today is $2.07
    The current trend is moderately bearish and MIST is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

MIST Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 41.6 Sell
Chaikin Money Flow: 3260813 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.17 - 2.69) Sell
Bollinger Bands (100): (1.7 - 2.32) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

MIST Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.13 Sell
20-day SMA: 2.45 Sell
50-day SMA: 2.18 Sell
200-day SMA: 1.76 Buy
8-day EMA: 2.16 Sell
20-day EMA: 2.28 Sell
50-day EMA: 2.05 Buy
200-day EMA: 0.99 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Milestone Pharmaceuticals, Inc. Earnings Growth & MIST Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.10 per share, and an increase next year of $0.12 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Milestone Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):